Is the patient's presentation more consistent with a chest infection or heart failure?

Distinguishing Chest Infection from Heart Failure

The differentiation between chest infection and heart failure requires systematic evaluation of clinical presentation, natriuretic peptide levels, and chest imaging—with BNP <100 pg/mL or NT-proBNP <300 pg/mL effectively ruling out acute heart failure, while elevated levels require integration with clinical and radiological findings to distinguish between the two conditions or identify their coexistence. 1

Algorithmic Approach to Diagnosis

Step 1: Clinical Assessment

Heart Failure Symptoms 2:

• Orthopnea (lying flat worsens breathing)
• Paroxysmal nocturnal dyspnea (waking gasping for air)
• Progressive dyspnea on exertion
• Lower extremity edema (bilateral, pitting)
• Weight gain (>3-4 lbs in 3-4 days)
• Reduced exercise tolerance without fever

Chest Infection Symptoms 1, 3:

• Fever (significantly more common in infection)
• Productive cough with sputum
• Acute onset (hours to days vs. gradual in HF)
• Pleuritic chest pain
• Recent infection exposure history

Step 2: Physical Examination Findings

Heart Failure Signs (requires ≥2 physical findings OR 1 physical + 1 lab criterion) 2:

• Peripheral edema (feet, ankles, legs, presacral)
• Pulmonary rales/crackles (typically bilateral, basilar)
• Elevated jugular venous pressure
• S3 gallop
• Cardiomegaly on examination
• Hepatojugular reflux

Infection Signs 3:

• Fever (temperature elevation)
• Tachycardia disproportionate to clinical status
• Localized crackles (may be unilateral)
• Absence of peripheral edema
• Normal jugular venous pressure

Step 3: Laboratory Differentiation

Natriuretic Peptides (Class I recommendation) 1:

• BNP <100 pg/mL or NT-proBNP <300 pg/mL: Heart failure unlikely
• BNP ≥500 pg/mL or NT-proBNP ≥900 pg/mL (age 50-75) or ≥1800 pg/mL (age ≥75): Heart failure likely

Critical caveat: Elevated natriuretic peptides occur in both conditions 1. Severe infections including pneumonia and sepsis can elevate BNP/NT-proBNP independent of heart failure.

Infection Markers 1, 3:

• Procalcitonin: Consider measuring to differentiate pneumonia and guide antibiotic therapy
• White blood cell count: Lower in COVID-19 pneumonia, may be elevated in bacterial infection 3
• CRP, ferritin, LDH: Significantly higher in respiratory infections 3
• Lymphocyte count: Lower in viral infections 3

Heart Failure Markers 3:

• NT-proBNP: Significantly higher in acute heart failure compared to infection alone
• Troponin: Should be measured in all patients 1

Step 4: Imaging Differentiation

Chest X-ray (Class I recommendation) 1:

Heart Failure Pattern 4:

• Cardiomegaly (77.8% in HF vs. 0% in COVID-19 pneumonia)
• Pleural effusions (77.8% in HF vs. 0% in infection alone)
• Interlobular septal thickening (Kerley B lines)
• Peribronchovascular interstitial thickening (44.4% in HF)
• Increased artery-to-bronchus ratio (55.6% in HF)
• Central/perihilar distribution of infiltrates
• Diffuse pattern more common in HF

Infection Pattern 3, 4:

• Peripheral ground-glass opacities (typical for viral pneumonia)
• Multifocal distribution (not diffuse)
• Consolidation (bacterial pneumonia)
• Absence of cardiomegaly
• Absence of pleural effusions (unless complicated)
• Normal cardiac silhouette

CT Chest findings 3, 4:

• Ground-glass opacities occur in both conditions
• Fluid redistribution signs favor HF: thickened fissures, interlobular septums, peribronchovascular interstitium
• Peripheral distribution favors infection
• Central distribution favors HF

Step 5: Integrated Diagnosis

Definite Heart Failure 5: Using validated scoring (0-14 points):

• Age ≥75 years (1 point)
• Orthopnea present (2 points)
• Lack of cough (1 point)
• Current loop diuretic use (1 point)
• Rales on exam (1 point)
• Lack of fever (2 points)
• Elevated NT-proBNP (4 points)
• Interstitial edema on chest x-ray (2 points)

Score interpretation:

• 0-5: Low likelihood of HF
• 6-8: Intermediate likelihood
• 9-14: High likelihood of HF

Common Clinical Scenarios

Both Conditions Coexist 6, 7

• 19% of patients hospitalized for dyspnea have both acute heart failure and respiratory infection
• Infection triggers HF decompensation in 25% of HF hospitalizations
• In-hospital mortality highest when both present (21.9% vs. lower with either alone)
• Treat both aggressively: diuretics for HF + antibiotics for infection

Pitfalls to Avoid

1. Don't rely on natriuretic peptides alone 1: Severe infections elevate BNP/NT-proBNP independent of heart failure
2. Don't assume absence of fever rules out infection 6: Some infections present without fever, especially in elderly
3. Don't dismiss HF because of fever 1: Patients can have both conditions simultaneously
4. Don't overlook cardiac examination 8: New murmurs may indicate endocarditis presenting as respiratory failure
5. Age matters 9: Patients ≥70 years with HF have higher pulmonary infection risk

Risk Factors for Infection in Heart Failure Patients 9

• Age ≥70 years
• Diabetes
• NYHA Class III
• LVEF ≤55%
• CRP ≥10 mg/L

When these factors present, maintain high suspicion for coexisting infection even with clear HF signs.

Urgent Echocardiography Indications 1

• De novo acute heart failure
• Unknown cardiac function
• Clinical deterioration despite treatment
• New cardiac murmur
• Suspected mechanical complications